120
Participants
Start Date
December 31, 2015
Primary Completion Date
January 4, 2026
Study Completion Date
January 4, 2026
Molecular Profiling & In Vivo drug testing in pPDX and organoid cultures
Molecular profiling of host tumour sample and pPDX will be performed and analyzed by an expert panel. In vitro organoid culture generation may also be performed if sufficient fresh tissue is available. Matched treatment recommendation based on profiling and in vivo pPDX drug testing results will be made, if available. This recommendation will be communicated to the primary oncologist.
RECRUITING
Princess Margaret Cancer Centre, Toronto
University Health Network, Toronto
OTHER